Quick Answer
Ginkgo Bioworks Holdings, Inc. reported Total Assets of $1.12 billion for the year ending 2025.
- Ginkgo Bioworks Holdings, Inc. showed a decrease of -18.7% in Total Assets from 2024 to 2025.
- This data is from Ginkgo Bioworks Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $1.73 billion | Q2 2021: $1.73 billion | Q3 2021: $2.15 billion | Q1 2022: $2.06 billion | Q2 2022: $1.99 billion | Q3 2022: $1.87 billion | Q1 2023: $2.42 billion | Q2 2023: $2.29 billion | Q3 2023: $2.03 billion | Q1 2024: $1.58 billion | Q2 2024: $1.63 billion | Q3 2024: $1.48 billion | Q1 2025: $1.29 billion | Q2 2025: $1.23 billion | Q3 2025: $1.19 billion.
- Over the full 6 years of available data (2020 to 2025), Ginkgo Bioworks Holdings, Inc.'s Total Assets has grown by 65.8%.
- Historical annual values: Fiscal year 2025: $1.12 billion | Fiscal year 2024: $1.38 billion | Fiscal year 2023: $1.67 billion | Fiscal year 2022: $2.54 billion | Fiscal year 2021: $2.07 billion | Fiscal year 2020: $675.15 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: